The AI reports the following. Note that the answers may contain errors.
The Swedish remote health service company Supernormal and the Finnish health technology company Nightingale Health have a direct commercial partnership in the field of preventive remote healthcare.
Supernormal uses advanced blood analysis technology developed by the Finnish company Nightingale Health to provide its own digital health services.
Supernormal’s customers provide a blood sample at local partner clinics throughout Sweden. The sample is analyzed in Nightingale’s laboratory, and the results, along with health monitoring, are provided to the customer digitally via Supernormal’s mobile application.
- Prevention of chronic diseases: Both companies focus on proactive healthcare rather than traditional medical care.
- Risk identification: The service aims to identify the risk of developing common lifestyle diseases (such as cardiovascular diseases and type 2 diabetes) years before actual symptoms appear.
3. Digitalization and ease of use (Remote health)
- No unnecessary physical appointments: Supernormal builds its services on speed and ease of use.
- Individual data: Both companies believe that when a person receives easy-to-read and accurate data on their own blood biomarkers, they can be motivated to make better lifestyle choices and manage their health risks independently.
In practice, Supernormal functions as a digital remote health platform and brand aimed at Swedish consumers, with Nightingale Health acting as the “engine” and medical blood analysis partner.